For the Quarter Ending December 2025
Clobetasol Propionate Prices in North America
- In the United States, the Clobetasol Propionate Price Index rose quarter-over-quarter in Q4 2025, driven by increased production costs and robust pharmaceutical demand.
- Clobetasol Propionate production costs increased, influenced by a 3.0% year-over-year PPI rise in November 2025 and higher energy expenses.
- Demand for Clobetasol Propionate strengthened, supported by a 2.0% year-over-year industrial production increase in December 2025.
- The pharmaceutical market outperformed in Q4 2025, with US spending on innovative therapies surging, boosting Clobetasol Propionate demand.
- A 2.7% year-over-year CPI increase in December 2025 indicated rising general inflation, impacting Clobetasol Propionate raw material costs.
- Natural gas feedstock costs gradually strengthened in the final months of 2025, alongside increased industrial electricity costs in November 2025.
- US pharmaceutical imports decreased in October 2025, while exports increased, reflecting shifts in trade flows.
- A 4.4% unemployment rate in December 2025 supported consumer healthcare spending, positively influencing Clobetasol Propionate demand.
Why did the price of Clobetasol Propionate change in December 2025 in North America?
- Rising production costs, including a 3.0% year-over-year PPI increase in November 2025, pressured Clobetasol Propionate prices.
- Strong pharmaceutical demand, supported by a 2.0% year-over-year industrial production rise in December 2025, boosted Clobetasol Propionate.
- Strengthening natural gas spot prices and industrial electricity costs in Q4 2025 contributed to higher Clobetasol Propionate prices.
Clobetasol Propionate Prices in APAC
- In China, the Clobetasol Propionate Price Index declined quarter-over-quarter in Q4 2025, influenced by weak consumer demand.
- The Clobetasol Propionate Price Forecast suggests continued stability or slight downward pressure due to market conditions in Q4 2025.
- Clobetasol Propionate production costs rose in Q4 2025, driven by upward pressure on global natural gas prices.
- Demand for Clobetasol Propionate faced headwinds in December 2025, as CPI was 0.8% and retail sales grew only 0.9%.
- China's Manufacturing Index expanded in December 2025, indicating growth in the broader industrial sector.
- Industrial production increased by 5.2% in December 2025, supporting overall chemical supply chain activity.
- The pharmaceutical raw material manufacturing industry in China saw increased total revenue in 2025, relying heavily on exports.
- Producer prices declined by 1.9% in December 2025, reflecting deflationary pressures on manufactured goods.
- Unemployment at 5.1% in December 2025, alongside cooled consumer confidence in Q4 2025, impacted healthcare spending.
Why did the price of Clobetasol Propionate change in December 2025 in APAC?
- Weak consumer demand, with CPI at 0.8% and retail sales growth at 0.9% in December 2025, limited pricing power.
- Producer prices declined by 1.9% in December 2025, indicating deflationary pressures on manufactured pharmaceutical products.
- Rising global natural gas prices in Q4 2025 increased production costs, creating upward pressure on the supply side.
Clobetasol Propionate Prices in Europe
- In Germany, the Clobetasol Propionate Price Index fell in Q4 2025, influenced by producer prices declining 2.5% year-on-year in December.
- Production costs faced upward pressure in 2025 due to elevated fuel and raw material prices impacting Clobetasol Propionate manufacturing.
- Demand was supported by an accelerating European API market in 2025 and Germany's moderate pharma growth in Q4 2025.
- Germany's Manufacturing Index showed a contracting trend in December 2025, indicating an overall industrial slowdown.
- Consumer prices increased 1.8% year-on-year in December 2025, supporting consumer purchasing power for healthcare products.
- Natural gas markets in Europe exhibited extreme volatility in Q4 2025, impacting Clobetasol Propionate production costs.
- Retail sales grew 1.1% year-on-year in November 2025; unemployment was 6.2% in December 2025, showing mixed consumer signals.
- Trade flows faced potential delays in Q4 2025 due to new threats impacting the Red Sea-Suez Canal route from Asia.
Why did the price of Clobetasol Propionate change in December 2025 in Europe?
- Producer prices declined 2.5% year-on-year in December 2025, reducing Clobetasol Propionate manufacturing costs.
- Consumer confidence registered -17.5 in December 2025, dampening overall demand for healthcare products.
- Natural gas markets in Europe experienced extreme volatility in Q4 2025, impacting energy-intensive production.
For the Quarter Ending September 2025
Clobetasol Propionate Price in North America
- In United States, Clobetasol Propionate Price Index rose in Q3 2025, driven by surging API costs and new import tariffs.
- Production costs for Clobetasol Propionate increased due to surging Active Pharmaceutical Ingredient costs in July 2025.
- New US tariffs on pharmaceutical imports, effective August 2025, significantly elevated Clobetasol Propionate input costs.
- Demand for Clobetasol Propionate supported by 5.42% retail sales increase and 4.3% unemployment in September 2025.
- The pharmaceutical supply chain faced Q3 2025 complications from logistical issues, risking Clobetasol Propionate shortages.
- General inflation, at 3.0% CPI in September 2025, contributed to higher operational costs for manufacturers.
- Wholesale electricity prices continued rising across the US in 2025, impacting Clobetasol Propionate manufacturing expenses.
- Pharmaceutical and Biotechnology market sentiment showed an upward trajectory in Q3 2025, with FDA drug approvals surging.
Why did the price of Clobetasol Propionate change in September 2025 in North America?
- Active Pharmaceutical Ingredient costs surged in July 2025, compounded by new US import tariffs from August 2025.
- Logistical issues in the pharmaceutical supply chain constrained availability, risking Clobetasol Propionate shortages in Q3 2025.
- Strong consumer spending, with retail sales up 5.42% and unemployment at 4.3% in September 2025, supported demand.
Clobetasol Propionate Price in APAC
- In China, the Clobetasol Propionate Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices and soft domestic demand.
- Clobetasol Propionate production costs trended lower in Q3 2025, with the Producer Price Index falling 2.3% year-on-year in September 2025.
- The demand outlook for Clobetasol Propionate was challenged by a 0.3% year-on-year decline in CPI in September 2025.
- Consumer confidence remained low at 89.6 in September 2025, alongside a 5.2% unemployment rate, impacting healthcare spending.
- The Manufacturing Index was contracting in September 2025, signaling reduced industrial activity affecting Clobetasol Propionate supply.
- Industrial production grew 6.5% year-on-year in September 2025, supporting underlying capacity for pharmaceutical manufacturing.
- Global chemical overcapacity persisted in 2025, contributing to elevated inventories and downward pressure on general chemical input costs.
- Demand for pharmaceutical products was bolstered by an aging population and rising chronic diseases in China during Q3 2025.
Why did the price of Clobetasol Propionate change in September 2025 in APAC?
- Producer Price Index fell 2.3% year-on-year, reducing Clobetasol Propionate production costs.
- Consumer Price Index declined 0.3% year-on-year, indicating soft domestic demand.
- Global chemical overcapacity and contracting Manufacturing Index pressured prices downward.
Clobetasol Propionate Price in Europe
- In Germany, the Clobetasol Propionate Price Index remained stable quarter-over-quarter in Q3 2025, balancing various cost and demand factors.
- Clobetasol Propionate production costs were influenced by a -1.7% year-over-year PPI decline, despite a 2.4% CPI in September 2025.
- Demand for Clobetasol Propionate was bolstered by a significant uplift in German pharmaceutical production in July 2025.
- The Clobetasol Propionate demand outlook is supported by an aging population and increasing chronic conditions in Q3 2025.
- Germany's Manufacturing Index was contracting in Q3 2025, signaling a broader industrial sector slowdown.
- Industrial production decreased by 1.0% year-over-year in September 2025, impacting non-API input costs.
- Retail sales increased by 0.2% year-over-year in September 2025, indicating stable consumer purchasing power.
- High electricity prices in Germany during Q3 2025 challenged industrial competitiveness and production expenses.
- The Clobetasol Propionate price forecast suggests continued stability, balancing cost pressures with steady pharmaceutical demand.
Why did the price of Clobetasol Propionate change in September 2025 in Europe?
- Producer prices for intermediate goods declined in Q3 2025, reducing Clobetasol Propionate manufacturing costs.
- German pharmaceutical production increased significantly in July 2025, supporting Clobetasol Propionate supply.
- Stable retail sales, up 0.2% year-over-year in September 2025, maintained consumer affordability for related products.
